Company Filing History:
Years Active: 2017
Title: The Innovations of Andreas Frei
Introduction
Andreas Frei is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of biochemistry through his innovative work on trifunctional crosslinking reagents. His research focuses on enhancing the detection and characterization of glycoprotein receptors, which are crucial for understanding various biological processes.
Latest Patents
Andreas Frei holds a patent for his invention titled "Trifunctional crosslinking reagents." This invention relates to reagents that carry a ligand-reactive group for conjugation to a ligand of interest, an aromatic hydrazine group for capturing oxidized receptor-glycopeptides, and an affinity group for the detection, isolation, and purification of captured glycopeptides. This patent is instrumental in developing methods for detecting, identifying, and characterizing interactions between ligands and their corresponding glycoprotein target receptors on living cells and in biological fluids. He has 1 patent to his name.
Career Highlights
Andreas is affiliated with ETH Zurich, a prestigious institution known for its cutting-edge research and innovation. His work at ETH Zurich has allowed him to collaborate with leading experts in the field, further enhancing the impact of his inventions.
Collaborations
Andreas has worked alongside notable colleagues such as Bernd Wollscheid and Ock-Youm Jeon. Their collaborative efforts have contributed to advancing research in glycoprotein interactions and related fields.
Conclusion
Andreas Frei's innovative contributions to biochemistry, particularly through his patent on trifunctional crosslinking reagents, highlight his role as a significant inventor in the scientific community. His work continues to influence the understanding of glycoprotein interactions, paving the way for future advancements in the field.